Can I read CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challenges on EtoBox?

CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challenges by Ayda Baghery Saghchy Khorasani; Amir-Mohammad Yousefi; Davood Bashash is a Immunology and Microbiology article available to read on EtoBox.

What is CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challenges about?

Adoptive cell treatment (ACT) utilizing chimeric antigen receptors (CAR) diverts the specificity of safe cells against a target-specific antigen and portrays exceptional potential for cancer treatment. While CAR T cell treatment has risen as a breakthrough with unprecedented results within the therapeutic procedures of human malignancies, different deficiencies including challenging and costly generation processes, strict patient qualification criteria, and undesirable toxicity have ruined its application. Unlike T cells, the application of natural killer (NK) cells has attracted consideration as a reasonable alternative owing to the major histocompatibility complex (MHC)-independency, shorter life expectancy, the potential to create an off-the-shelf immune product, and potent antitumor properties. In this article, we provide an updated review of the differences between CAR T and CAR NK cells, current enhancements in CAR NK design, the available sources for collecting NK cells, and strategies for the transduction step of the CARs to NK cells. Furthermore, we focus on the published and ongoing preclinical and clinical studies of CAR NK treatment strategies both in hematologic malign

Who reads CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challenges?

Author

Ayda Baghery Saghchy Khorasani; Amir-Mohammad Yousefi; Davood Bashash

Publisher

Elsevier BV

Published

2022

Language

EN

Field

Immunology and Microbiology (Life Sciences)